Emergency Contraception: Two Steps Forward, One Step Back

Anne R. Davis; Piyapa Praditpan

doi:10.1055/s-0036-1572438

Seminars in Reproductive Medicine, Inhaltsverzeichnis

Semin Reprod Med 2016; 34(03): 152-158
DOI: 10.1055/s-0036-1572438

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Emergency Contraception: Two Steps Forward, One Step Back

Anne R. Davis

¹Division of Family Planning, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York City, New York

,

Piyapa Praditpan

¹Division of Family Planning, Department of Obstetrics and Gynecology, Columbia University Medical Center, New York City, New York

› Institutsangaben

Abstract

Emergency contraceptives can prevent pregnancy, when used after unprotected sex around the time of ovulation. In the past 15 years, access to emergency contraception (EC) in the United States has increased and more women use it. Emerging data may tailor EC prescribing based on patient weight and starting other contraception. There are several EC options—oral levonorgestrel and oral ulipristal acetate and the copper intrauterine device. Ideally, women should have EC access at low or no cost. Yet, several barriers—limited patient and provider knowledge about EC, cost, EC stocking practices, and state and federal laws exempting providers from supplying EC—make it difficult to integrate this time-sensitive treatment into women's reproductive health care.

Keywords

emergency contraception - Affordable Care Act - over-the-counter - levonorgestrel - ulipristal acetate - copper intrauterine device

Volltext

Referenzen

References
1 Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception 2007; 75 (6, Suppl): S16-S30
2 Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Hum Reprod 2012; 27 (7) 1994-2000
3 Ortiz ME, Croxatto HB, Bardin CW. Mechanisms of action of intrauterine devices. Obstet Gynecol Surv 1996; 51 (12, Suppl): S42-S51
4 Wilcox AJ, Weinberg CR, Armstrong EG, Canfield RE. Urinary human chorionic gonadotropin among intrauterine device users: detection with a highly specific and sensitive assay. Fertil Steril 1987; 47 (2) 265-269
5 Segal SJ, Alvarez-Sanchez F, Adejuwon CA, Brache de Mejia V, Leon P, Faundes A. Absence of chorionic gonadotropin in sera of women who use intrauterine devices. Fertil Steril 1985; 44 (2) 214-218
6 Brache V, Cochon L, Deniaud M, Croxatto HB. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trials of emergency contraception regimens. Contraception 2013; 88 (5) 611-618
7 Glasier A, Cameron ST, Blithe D , et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011; 84 (4) 363-367
8 Kapp N, Abitbol JL, Mathé H , et al. Effect of body weight and BMI on the efficacy of levonorgestrel emergency contraception. Contraception 2015; 91 (2) 97-104
9 Gemzell-Danielsson K, Kardos L, von Hertzen H. Impact of bodyweight/body mass index on the effectiveness of emergency contraception with levonorgestrel: a pooled-analysis of three randomized controlled trials. Curr Med Res Opin 2015; 31 (12) 2241-2248
10 European Medicines Agency. Levonorgestrel and ulipristal acetate remain suitable emergency contraceptives for all women, regardless of body mass index. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/07/news_detail_002145.jsp&mid=WC0b01ac058004d5c1 . Accessed October 31, 2015
11 Creinin MD, Schlaff W, Archer DF , et al. Progesterone receptor modulator for emergency contraception: a randomized controlled trial. Obstet Gynecol 2006; 108 (5) 1089-1097
12 Glasier AF, Cameron ST, Fine PM , et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis. Lancet 2010; 375 (9714) 555-562
13 Centers for Disease Control and Prevention. U.S. Selected practice recommendations for contraceptive use, 2013: Adapted from the World Health Organization Selected practice recommendations for contraceptive use, 2nd ed. Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6205a1.htm . Accessed October 31, 2015
14 Brache V, Cochon L, Duijkers IJM , et al. A prospective, randomized, pharmacodynamic study of quick-starting a desogestrel progestin-only pill following ulipristal acetate for emergency contraception. Hum Reprod 2015; 30 (12) 2785-2793
15 Cameron ST, Berger C, Michie L, Klipping C, Gemzell-Danielsson K. The effects on ovarian activity of ulipristal acetate when ‘quickstarting’ a combined oral contraceptive pill: a prospective, randomized, double-blind parallel-arm, placebo-controlled study. Hum Reprod 2015; 30 (7) 1566-1572
16 Hoogland HJ, Skouby SO. Ultrasound evaluation of ovarian activity under oral contraceptives. Contraception 1993; 47 (6) 583-590
17 Turok DK, Jacobson JC, Dermish AI , et al. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Contraception 2014; 89 (3) 222-228
18 Henry J. Kaiser Family Foundation. Key facts about the uninsured. Available at: http://kff.org/uninsured/fact-sheet/key-facts-about-the-uninsured-population . Accessed October 19, 2015
19 Guttmacher Institute. Fewer U.S. women of reproductive age were uninsured in 2014. Available at: http://www.guttmacher.org/media/inthenews/2015/09/22/index.html . Accessed November 25, 2015
20 US Department of Health and Human Services. What marketplace plans cover. Available at: https://www.healthcare.gov/coverage/birth-control-benefits . Accessed October 19, 2015
21 Novikova N, Weisberg E, Fraser IS. Does readily available emergency contraception increase women's awareness and use?. Eur J Contracept Reprod Health Care 2009; 14 (1) 39-45
22 Abbott J, Feldhaus KM, Houry D, Lowenstein SR. Emergency contraception: what do our patients know?. Ann Emerg Med 2004; 43 (3) 376-381
23 Adrian C, Kim I, Chu V, Kaneshiro B. Accuracy of information on emergency contraception on the Internet. J Reprod Med 2013; 58 (7–8) 291-296
24 Yen S, Parmar DD, Lin EL, Ammerman S. Emergency contraception pill awareness and knowledge in uninsured adolescents: high rates of misconceptions concerning indications for use, side effects, and access. J Pediatr Adolesc Gynecol 2015; 28 (5) 337-342
25 Cremer M, Holland E, Adams B , et al. Adolescent comprehension of emergency contraception in New York City. Obstet Gynecol 2009; 113 (4) 840-844
26 Jatlaoui TC, Riley H, Curtis KM. Safety data for levonorgestrel, ulipristal acetate and Yuzpe regimens for emergency contraception. Contraception 2015; 93 (2) 93-112
27 Schwarz EB, Kavanaugh M, Douglas E, Dubowitz T, Creinin MD. Interest in intrauterine contraception among seekers of emergency contraception and pregnancy testing. Obstet Gynecol 2009; 113 (4) 833-839
28 Schwarz EB, Papic M, Parisi SM, Baldauf E, Rapkin R, Updike G. Routine counseling about intrauterine contraception for women seeking emergency contraception. Contraception 2014; 90 (1) 66-71
29 Wright RL, Frost CJ, Turok DK. A qualitative exploration of emergency contraception users' willingness to select the copper IUD. Contraception 2012; 85 (1) 32-35
30 Kavanaugh ML, Williams SL, Schwarz EB. Emergency contraception use and counseling after changes in United States prescription status. Fertil Steril 2011; 95 (8) 2578-2581
31 Batur P, Cleland K, McNamara M, Wu J, Pickle S ; EC Survey Group. Emergency contraception: a multispecialty survey of clinician knowledge and practices. Contraception 2016; 93 (2) 145-152
32 Gold MA, Wolford JE, Smith KA, Parker AM. The effects of advance provision of emergency contraception on adolescent women's sexual and contraceptive behaviors. J Pediatr Adolesc Gynecol 2004; 17 (2) 87-96
33 Raine TR, Harper CC, Rocca CH , et al. Direct access to emergency contraception through pharmacies and effect on unintended pregnancy and STIs: a randomized controlled trial. JAMA 2005; 293 (1) 54-62
34 American Society for Emergency Contraception. EC on the Shelf: Real-World Access in the OTC Era. Available at: http://americansocietyforec.org/uploads/3/2/7/0/3270267/asec_ec_access_report.pdf . Accessed October 30, 2015
35 Breiding MJ, Smith SG, Basile KC, Walters ML, Chen J, Merrick MT. Prevalence and characteristics of sexual violence, stalking, and intimate partner violence victimization—national intimate partner and sexual violence survey, United States, 2011. MMWR Surveill Summ 2014; 63 (8) 1-18
36 Committee on Health Care for Underserved Women. ACOG Committee Opinion no. 592: Sexual assault. Obstet Gynecol 2014; 123 (4) 905-909
37 American College of Emergency Physicians. Evaluation and management of the sexually assaulted or sexually abused patient, 2nd ed. Available at: https://www.acep.org/Clinical—Practice-Management/Management-of-the-Patient-with-the-Complaint-of-Sexual-Assault . Accessed November 30, 2015
38 U.S. Department of Justice, Office of Violence Against Women. A national protocol for sexual assault medical forensic examinations, 2nd ed. Available at: https://www.ncjrs.gov/pdffiles1/ovw/241903.pdf . Accessed November 30, 2015
39 Guttmacher Institute. State policies in brief: emergency contraception. Available at: http://www.guttmacher.org/statecenter/spibs/spib_EC.pdf . Accessed October 30, 2015
40 Patel A, Roston A, Tilmon S , et al. Assessing the extent of provision of comprehensive medical care management for female sexual assault patients in US hospital emergency departments. Int J Gynaecol Obstet 2013; 123 (1) 24-28
41 American Society for Emergency Contraception. The cost of emergency contraception: results from a nationwide survey. Available at: http://americansocietyforec.org/uploads/3/2/7/0/3270267/asecpricingreport.pdf . Accessed October 30, 2015
42 Not 2 Late. How Much Do Emergency Contraceptives Cost? Available at: http://ec.princeton.edu/questions/eccost.html . Accessed November 24, 2015
43 Frost JJ, Frohwirth L, Zolna MR. Contraceptive needs and services, 2013 update. Guttmacher Institute. Available at: http://www.guttmacher.org/pubs/win/contraceptive-needs-2013.pdf . Accessed November 24, 2015
44 Chuang CH, Mitchell JL, Velott DL , et al. Women's awareness of their contraceptive benefits under the Patient Protection and Affordable Care Act. Am J Public Health 2015; 105 (Suppl. 05) S713-S715
45 Burwell, Secretary of Health and Human Services, et al, vs Hobby Lobby Stores, Inc, et al. Docket No. 13–354. Argued March 25, 2014. Decided June 30, 2014. Available at: http://www.supremecourt.gov/opinions/13pdf/13-354_olp1.pdf . Accessed October 30, 2015
46 Wheaton College vs Sylvia Burwell, Secretary of Health and Human Services, et al. On application for injunction [July 3, 2014]. Docket No. 13A1284. Available at: http://www.supremecourt.gov/opinions/13pdf/13a1284_ap6c.pdf . Accessed October 30, 2015
47 Sobel L, Salganikoff A. Round 2 on the Legal Challenges to Contraceptive Coverage: Are Nonprofits “Substantially Burdened” by the “Accommodation?” Kaiser Family Foundation. Available at: http://kff.org/womens-health-policy/issue-brief/round-2-on-the-legal-challenges-to-contraceptive-coverage-are-nonprofits-substantially-burdened-by-the-accommodation . Accessed November 24, 2015
48 Morrell KM, Chavkin W. Conscientious objection to abortion and reproductive healthcare: a review of recent literature and implications for adolescents. Curr Opin Obstet Gynecol 2015; 27 (5) 333-338
49 Richman AR, Daley EM, Baldwin J, Kromrey J, O'Rourke K, Perrin K. The role of pharmacists and emergency contraception: are pharmacists' perceptions of emergency contraception predictive of their dispensing practices?. Contraception 2012; 86 (4) 370-375
50 Finer LB, Zolna MR. Shifts in intended and unintended pregnancies in the United States, 2001-2008. Am J Public Health 2014; 104 (Suppl. 01) S43-S48